PHARMANUTRA S.P.A. (761 F) stock market data APIs
€46.184
-0.3(-0.6%)
as of July 2, 2025
Try our APIs with
free plan!
PHARMANUTRA S.P.A. Financial Data Overview
Price chart is built with
Anychart
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and software for body bioimpedance analysis. The company sells its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
Prev. Close
46.184
Open
45.8889
High
46.184
Low
45.8889
52 wk Range
44.2679-59.1874
Market Cap
445 M
P/E Ratio
26.9883
Shares Outstanding
9 591 K
Revenue
116 M
Dividends (Yield)
0.0219
Beta
0.297
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PHARMANUTRA S.P.A. data using free add-ons & libraries
Get PHARMANUTRA S.P.A. Fundamental Data
PHARMANUTRA S.P.A. Fundamental data includes:
- Net Revenue: 116 M
- EBITDA: 30 242 K
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PHARMANUTRA S.P.A. News
New
PHARMANUTRA S.P.A.: NEW DISTRIBUTION AGREEMENTS IN INDONESIA, KUWAIT AND MEXICO
PISA, Italy, Jan. 4, 2023 /CNW/ -- PharmaNutra S.p.A. (MTA: PHN), a company specialised in mineral and iron-based nutritional supplements and medical devices for muscles and joints health, is pleased...
PHARMANUTRA S.P.A.: NEW LICENCE GRANTED IN THE U.S.A.
The US Patent Office has granted the company a patent for use of Cetylated Fatty Acids (CFA), the basic functional ingredient in the Cetilar® product line. PISA, Italy, Jan. 17, 2022 /PRNewswire/ --...
PHARMANUTRA: NEW SCIENTIFIC STUDIES ON SUCROSOMIAL® TECHNOLOGY APPLIED TO IRON
PISA, Italy, Dec. 21, 2021 /CNW/ -- Since 2003, the scientific research activity of PharmaNutra (MTA; Ticket PHN), a group of companies specialized in the development, production and distribution of r...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
